Camber Launches Generic Opana®
Piscataway, NJ, May 4, 2018– Camber Pharmaceuticals is pleased to announce the addition of Oxymorphone Tablets to our growing portfolio of products.
Oxymorphone tablets are the generic version of Opana®. Oxymorphone is used to treat moderate to severe pain.
Oxymorphone tablets are available in 5 and10mg- 100ct bottles.
Camber’s commitment to its customers is to bring the highest quality generic pharmaceuticals to the market and provide a level of excellence in service, supply and affordability.
If you would like more information about this topic, please contact Kirk Hessels at 732.529.0430 or email at [email protected].
Recent articles
- Camber Launches Abacavir and Lamivudine Tablets, USP
- Camber’s Parent Company, Hetero, Partners with the Gates Foundation to Supply Generic Lenacapavir for HIV Prevention
- Camber Adds 800 mg Darunavir Tablets to Product Family
- Camber Expands Portfolio with 10 New Generic Drug Launches in Q3 2025
- Camber Launches Indomethacin Suppositories
- Camber Launches Voriconazole for Injection





